Last reviewed · How we verify
NCT05586347
Relationship Between Perioperative Carotid Blood Flow Monitoring and Cerebral Function Protection in Cardiac Surgery
NA trial testing Nicardipine in Coronary Artery Bypass Grafting in 64 participants. Completed in 30 September 2022.
22 September 2022
Quick facts
| Lead sponsor | Nanjing First Hospital, Nanjing Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 64 |
| Start date | 22 April 2022 |
| Primary completion | 22 September 2022 |
| Estimated completion | 30 September 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Nicardipine (NICARDIPINE) — full drug profile →
- normal saline
Conditions studied
- Coronary Artery Bypass Grafting — all drugs for Coronary Artery Bypass Grafting →
- Cardiopulmonary Bypass — all drugs for Cardiopulmonary Bypass →
Sponsor
Nanjing First Hospital, Nanjing Medical University
Who can join
Adults 60 to 80, any sex, with Coronary Artery Bypass Grafting or Cardiopulmonary Bypass. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Postoperative cognitive dysfunction (POCD) is a common complication of cardiac surgery, mainly manifested as mental confusion, anxiety, personality change and memory impairment, which seriously affects the quality of life of patients after surgery.Attention should be paid to the protection of neurological function in patients undergoing cardiac surgery during perioperative period.Nicardipine can selectively act on coronary arteries and cerebral vessels, increase coronary artery and cerebral blood flow, relieve coronary heart disease angina pectoris, protect brain tissue.The cerebral protective effect of nicardipine on cardiovascular surgery under CPB deserves further clinical study.About 15-20% of cardiac output (CO) in healthy adults is allocated to the brain , and cerebral blood flow is supplied by bilateral internal carotid artery (ICA) and vertebral artery (VA), among which ICA provides about 70%-80% of cerebral perfusion flow .However, the location of the internal carotid artery is superficial, the anatomical variation is less, and the ultrasonic Doppler technique is portable and simple to measure. It may be of certain clinical value to use the ultrasonic detection technology to quickly evaluate the cerebral perfusion during the perioperative period, and to early detect and avoid the intraoperative brain function injury.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05586347
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nicardipine
Trials testing the same drug.
- NCT07364201 — A Comparison of Nicardipine and Labetalol for Blood Pressure Control in Intensive Care Patients After Hemorrhagic Stroke · NA · completed
- NCT07044232 — NICardipine for Fast Achievement of Systolic BP Targets in ICH · Phase 4 · not yet recruiting
- NCT06093893 — Hypotensive Anesthesia for Orthognathic Surgery · Phase 4 · completed
- NCT06130527 — Comparison of the Effects of Nicardipine and Remifentanil on Surgical Visual Field · NA · unknown
- NCT05625503 — Dilution of Verapamil During Intraarterial Administration · EARLY_PHASE1 · completed
Other recruiting trials for Coronary Artery Bypass Grafting
Currently open trials in the same condition.
- NCT07116733 — Desflurane vs. Propofol for Cardiac Anesthesia · Phase 3 · recruiting
- NCT07172620 — Safety and Effectiveness of No-touch Technique for Ascending Aorta in MICS-CABG · recruiting
- NCT06981390 — Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG · NA · recruiting
- NCT06787651 — Comparison of RIMA-SVG and Ao-SVG Techniques in Coronary Artery Bypass Grafting · NA · active not recruiting
- NCT06798714 — The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery · Phase 4 · recruiting
Other Nanjing First Hospital, Nanjing Medical University trials
Trials by the same sponsor.
- NCT07349979 — PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy · NA · not yet recruiting
- NCT07505056 — Jianpi Lishi Jiedu Granules for Prevention of Postoperative Recurrence in Colorectal Advanced Adenomas · Phase 3 · not yet recruiting
- NCT07397234 — Thyroid Cartilage Plane VS Superior Laryngeal Nerve Space Block in Awake Tracheal Intubation · NA · not yet recruiting
- NCT07455448 — Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study · completed
- NCT07385885 — Ultrasound-guided Non-invasive Simulation in Anesthesia Residency Training · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05586347 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nanjing First Hospital, Nanjing Medical University
- Last refreshed: 19 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05586347.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing